LAST PRICE - AT THE CLOSE
EMRAF is DOWN -2% since the begininning of the year
EMRAF is UP 7% ABOVE 20 day SMA
EMRAF is UP 2% ABOVE 200 day SMA
PROFITABLE: YES
EPS: $1.5295
EARNINGS MOMENTUM: N/A
N/A INCREASE IN QTRLY EARNINGS
P/E RATIO IS: 21.9648
INCOME TO DEBT RATIO: 0.06
 |
THE STOCK IS 29.7% AWAY FROM ALL-TIME HIGHS OF $52.56 |
 |
EMRAF IS DOWN -2% SINCE THE BEGINNING OF THE YEAR |
 |
EMRAF IS DOWN -14% OVER THE PAST 12 MONTHS |
 |
EMRAF IS UP 9% OVER THE PAST 1 MONTH |
 |
N/A% OF ALL EMRAF INVESTORS ARE BETTING AGAINST EMRAF |
 |
NUM INVESTORS SHORT EMRAF HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|
 |
EMRAF moved up 0 in the previous minute |
 |
EMRAF is up 0 over the last hour |
 |
EMRAF is up 4.5% over the last 5 days |
 |
EMRAF is 3.9 above its 8 day SMA |
| $36.76 |   DAY |
$36.96 |
| $36.30 | PREVIOUS DAY |
$36.59 |
| $35.05 | WEEK |
$36.59 |
| $33.44 | MONTH |
$36.59 |
| $31.85 |  YEAR |
$43.89 |
EMRAF is mentioned N/A less than normal on 
EMRAF is mentioned N/A times in an average day on 
